Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CABA Cabaletta Bio

盘前交易 07-21 04:18:35 EDT

2.75

-0.08

-2.83%

盘前2.84

+0.09+3.27%

04:06 EDT

最高2.87	最低2.74	成交量269.20万
今开2.83	昨收2.83	日振幅4.59%
总市值4.48亿	流通市值3.93亿	总股本1.63亿
成交额755.43万	换手率1.88%	流通股本1.43亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CABA","market":"US","secType":"STK","nameCN":"Cabaletta Bio","latestPrice":2.75,"timestamp":1784577600000,"preClose":2.83,"halted":0,"volume":2691957,"hourTrading":{"tag":"盘前","latestPrice":2.84,"preClose":2.75,"latestTime":"04:06 EDT","volume":31,"amount":88.22999899999999,"timestamp":1784621164383,"change":0.09,"changeRate":0.032727,"amplitude":0.003636},"delay":0,"changeRate":-0.02826855123674914,"floatShares":143000000,"shares":163000000,"eps":-1.842596,"marketStatus":"盘前交易","change":-0.08,"latestTime":"07-21 04:18:35 EDT","open":2.83,"high":2.87,"low":2.74,"amount":7554307.023207,"amplitude":0.045936,"askPrice":2.96,"askSize":40,"bidPrice":2.7,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.842596,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784640600000},"marketStatusCode":1,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":2.75,"preHourTrading":{"tag":"盘前","latestPrice":2.84,"preClose":2.75,"latestTime":"04:06 EDT","volume":31,"amount":88.22999899999999,"timestamp":1784621164383,"change":0.09,"changeRate":0.032727,"amplitude":0.003636},"postHourTrading":{"tag":"盘后","latestPrice":2.74,"preClose":2.75,"latestTime":"19:34 EDT","volume":10349,"amount":28450.0658,"timestamp":1784590449474,"change":-0.01,"changeRate":-0.003636,"amplitude":0.003636},"volumeRatio":0.775377,"impliedVol":0.5759,"impliedVolPercentile":0.148},"requestUrl":"/m/hq/s/CABA","defaultTab":"news","newsList":[{"id":"1189341988","title":"Cabaletta Bio定价1.5亿美元承销发行，礼来等多家机构参与认购","url":"https://stock-news.laohu8.com/highlight/detail?id=1189341988","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189341988?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:37","pubTimestamp":1777891036,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Cabaletta Bio近日宣布，其承销公开发行的5172.5万股普通股已完成定价。此次发行定价为每股2.90美元，与纳斯达克规则下的市价持平，预计在扣除承销折扣、佣金及发行费用前，募集资金总额将达1.5亿美元。发行计划预计于2026年5月5日左右完成，具体时间取决于惯例交割条件的满足情况。所有发行股份均由Cabaletta Bio售出。Cabaletta Bio是一家专注于为自身免疫性疾病患者开发治愈性靶向细胞疗法的生物技术公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4139","CABA","BK4099","03160","BK4588","USA","BK4604","BK4555","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182797856","title":"首批患者接受基于Cellares自动化Cell Shuttle™平台生产的Cabaletta Bio药物Rese-Cel治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1182797856","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182797856?lang=zh_cn&edition=full","pubTime":"2026-04-15 04:33","pubTimestamp":1776198794,"startTime":"0","endTime":"0","summary":"由Cellares自动化Cell Shuttle™平台完成生产的Cabaletta Bio公司Rese-Cel细胞疗法，已完成对首批患者的给药。这一里程碑标志着自动化生产技术正式进入临床治疗阶段，为细胞疗法的大规模标准化生产开辟了新路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617579454","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.10%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617579454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617579454?lang=zh_cn&edition=full","pubTime":"2026-03-06 01:18","pubTimestamp":1772731138,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日01时18分，Cabaletta Bio, Inc.股票出现异动，股价快速跳水5.10%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。其相关个股中，Impact Biomedical, Inc.、Tenaya Therapeutics, Inc.、Tango Therapeutics, Inc.涨幅较大，Quince Therapeutics, Inc.、Ensysce Biosciences, Inc.、Impact Biomedical, Inc.较为活跃，换手率分别为369.25%、210.64%、176.16%，振幅较大的相关个股有Impact Biomedical, Inc.、Ensysce Biosciences, Inc.、Tango Therapeutics, Inc.，振幅分别为63.63%、49.85%、33.68%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306011858a6a792cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306011858a6a792cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614050383","title":"Cabaletta Bio, Inc.盘中异动 早盘快速拉升5.17%报3.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614050383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614050383?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:41","pubTimestamp":1772030475,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时41分，Cabaletta Bio, Inc.股票出现波动，股价快速拉升5.17%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225224116a4c7ae2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225224116a4c7ae2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609319195","title":"Cabaletta Bio, Inc.盘中异动 快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609319195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609319195?lang=zh_cn&edition=full","pubTime":"2026-02-05 00:56","pubTimestamp":1770224186,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日00时56分，Cabaletta Bio, Inc.股票出现异动，股价大幅跳水5.02%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205005626a47cab1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205005626a47cab1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164932996","title":"Cabaletta Bio 与 Cellares 合作获得 Rese-Cel 临床生产新药申请修正案许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1164932996","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164932996?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:32","pubTimestamp":1768221165,"startTime":"0","endTime":"0","summary":"Cabaletta Bio 已成功获得监管机构对其新药申请（IND）修正案的许可，该修正案涉及使用 Cellares 公司的自动化平台进行 Rese-Cel 的临床生产。这一进展标志着 Cabaletta Bio 在推进其细胞疗法候选药物 Rese-Cel 的临床开发方面迈出了重要一步。通过利用 Cellares 的先进自动化技术，Cabaletta Bio 旨在提高生产效率、确保产品质量的一致性，并加速 Rese-Cel 的临床供应。此次合作结合了 Cabaletta Bio 在细胞治疗领域的专业知识和 Cellares 的创新型制造解决方案，有望为患者带来更高效、可靠的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518204985","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.14%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518204985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518204985?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:07","pubTimestamp":1741633666,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时07分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.14%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030746abf37776&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030746abf37776&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517925605","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.01%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517925605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517925605?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:39","pubTimestamp":1741203592,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时39分，Cabaletta Bio, Inc.股票出现波动，股价快速上涨5.01%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.96%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306033952989d886d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306033952989d886d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517605283","title":"Cabaletta Bio, Inc.盘中异动 大幅拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517605283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517605283?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:49","pubTimestamp":1741103373,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时49分，Cabaletta Bio, Inc.股票出现异动，股价快速上涨5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234933a25f1a3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234933a25f1a3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516654554","title":"Cabaletta Bio, Inc.盘中异动 下午盘大幅跳水5.24%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654554?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:20","pubTimestamp":1741026001,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时20分，Cabaletta Bio, Inc.股票出现异动，股价急速跳水5.24%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022001abe675dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022001abe675dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514738903","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514738903?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:34","pubTimestamp":1740753266,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时34分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.23%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822342696341a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822342696341a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514862257","title":"Cabaletta Bio, Inc.盘中异动 临近收盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862257?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:30","pubTimestamp":1740601806,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时30分，Cabaletta Bio, Inc.股票出现异动，股价急速下跌5.05%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227043006abde3ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227043006abde3ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720852","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720852?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:57","pubTimestamp":1740409041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时57分，Cabaletta Bio, Inc.股票出现异动，股价快速下挫5.34%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225721962e9f56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225721962e9f56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512486563","title":"Cabaletta Bio, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512486563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512486563?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:15","pubTimestamp":1739978156,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时15分，Cabaletta Bio, Inc.股票出现波动，股价大幅跳水5.15%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192315569628d512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192315569628d512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165328","title":"Cabaletta Bio, Inc.盘中异动 大幅上涨5.17%报2.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165328?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889482,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.17%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238029889fe36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238029889fe36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511929816","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.00%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511929816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511929816?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:51","pubTimestamp":1739548284,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时51分，Cabaletta Bio, Inc.股票出现异动，股价大幅拉升5.00%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214235125a246130c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214235125a246130c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525110","title":"Cabaletta Bio, Inc.盘中异动 早盘快速上涨5.24%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525110?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:41","pubTimestamp":1739457700,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时41分，Cabaletta Bio, Inc.股票出现波动，股价大幅拉升5.24%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322414198842dcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322414198842dcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510838707","title":"Cabaletta Bio, Inc.盘中异动 快速下跌5.14%报2.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510838707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510838707?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:32","pubTimestamp":1739284363,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时32分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.14%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223244abcb065e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223244abcb065e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510990798","title":"Cabaletta Bio, Inc.盘中异动 快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510990798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510990798?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:11","pubTimestamp":1739214702,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时11分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110311439880ae1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110311439880ae1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509420817","title":"Cabaletta Bio, Inc.盘中异动 早盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509420817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509420817?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:54","pubTimestamp":1738940044,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时54分，Cabaletta Bio, Inc.股票出现异动，股价急速上涨5.00%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225404987db19f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225404987db19f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cabalettabio.com","stockEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":-0.0317},{"period":"3month","weight":-0.1214},{"period":"6month","weight":0.1752},{"period":"1year","weight":0.6467},{"period":"ytd","weight":0.2557}],"compareEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0062},{"period":"3month","weight":0.054},{"period":"6month","weight":0.0827},{"period":"1year","weight":0.1825},{"period":"ytd","weight":0.0882}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发工程化T细胞疗法，这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的，也许是治疗性的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.066202},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.093114},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.184529},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.054377},{"month":5,"riseRate":0.571429,"avgChangeRate":0.105131},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.065922},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.014983},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.019431},{"month":9,"riseRate":0.666667,"avgChangeRate":0.071635},{"month":10,"riseRate":0.666667,"avgChangeRate":0.33715},{"month":11,"riseRate":0.714286,"avgChangeRate":0.286048},{"month":12,"riseRate":0.428571,"avgChangeRate":0.015878}],"exchange":"NASDAQ","name":"Cabaletta Bio","nameEN":"Cabaletta Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cabaletta Bio,CABA,Cabaletta Bio股票,Cabaletta Bio股票老虎,Cabaletta Bio股票老虎国际,Cabaletta Bio行情,Cabaletta Bio股票行情,Cabaletta Bio股价,Cabaletta Bio股市,Cabaletta Bio股票价格,Cabaletta Bio股票交易,Cabaletta Bio股票购买,Cabaletta Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}